Product
Recombinant Human Interferon α-2b
1 clinical trial
1 indication
Indication
Herpes ZosterClinical trial
A Multicenter, Randomized, Double-blind, Controlled, Non-inferiority Phase III Clinical Trial of Recombinant Human Interferon Alpha-2b Gel (ZK-A03) in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient ManufacturerStatus: Not yet recruiting, Estimated PCD: 2023-07-30